club earnings

Earnings

Palo Alto dips after another strong quarter — why we’re bullish on the year ahead

Shares of Palo Alto Networks fell on Wednesday, even after the cybersecurity company reported better-than-expected quarterly results and raised its full-year

Read More
Earnings

We’re raising our price target on retail stock TJX after a beat-and-raise quarter

TJX Companies on Wednesday reported a beat-and-raise quarter as consumers continue to focus on getting the most bang for their

Read More
Earnings

Cramer says ‘I don’t want to fight Disney anymore’ — here is what’s next for the stock

We’re fed up with Disney . “It’s a hated stock,” Jim Cramer said Thursday during the November Monthly Meeting for

Read More
Earnings

We’re increasing our Cisco Systems price target after an AI-fueled beat and raise

Cisco Systems shares spiked higher Wednesday evening after the networking company delivered a quarterly beat and outlook raise. Another quarter

Read More
Earnings

Here’s our price target and rating on Qnity, our newest stock to ride the AI chip boom

Call us believers in the Qnity Electronics story. We’re instituting a buy-equivalent 1 rating and price target of $110 a

Read More
Earnings

Texas Roadhouse is in a tough spot but still delivering on everything it can control

Texas Roadhouse on Thursday evening reported a mixed third quarter as stubbornly high beef prices continued to weigh on profitability,

Read More
Earnings

Solstice earnings brought no big surprises, but shares of the spinoff remain volatile

Solstice Advanced Materials declined Thursday following the company’s third-quarter earnings. We expect shares of this newly independent company to remain

Read More
Earnings

DuPont’s stock surge to 52-week highs takes a pause. But we still see plenty of upside ahead

DuPont shares took a breather Thursday after a scorching four-session rally. The reason? There was some noise around the quarterly

Read More
Earnings

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.